Cervical Cytology: Reading the Pap Test and Bethesda

Reviewed by the LabReadAI medical team
Cervical Cytology: Reading the Pap Test and Bethesda

The words "cervical cytology" and the unfamiliar abbreviations ASC-US or LSIL in a result often frighten more than the test itself. Yet cytology is a screen — a preventive check that looks for early cell changes while everything is still easy to manage. Let's calmly go through what cervical cytology shows, how to read results by the Bethesda system, and why an abnormality is not yet cancer.

What Cervical Cytology Shows

Cytology (the Pap test) examines cells taken from the surface and canal of the cervix. Under a microscope or by machine it is assessed whether the cells have changes. The goal is to catch precancerous states at an early stage, long before symptoms appear. It is a screen of healthy women, not a test of "do I have cancer".

Conventional and Liquid-Based Pap Test

There are two methods. Conventional cytology: the material is smeared on a slide. Liquid-based cytology: cells are placed in a special solution, giving a cleaner preparation and allowing an HPV test from the same sample. The liquid-based method is now preferred, but both assess one thing — the state of cervical cells.

How Cytology Is Read: the Bethesda System

Results are reported by the single Bethesda system. Key categories: NILM — normal, no changes; ASC-US — atypical cells of undetermined significance (mild uncertainty); LSIL — low-grade changes (usually linked to HPV and often self-resolving); HSIL — high-grade changes needing attention; atypical glandular cells are noted separately. It is a gradation of risk, not a verdict.

Atypical Cells and HPV: the Link

Most cervical changes are linked to the human papillomavirus. So cytology is often supplemented with a test for high-oncogenic-risk HPV — this co-testing gauges the situation more accurately. Which virus types are dangerous and what their detection means is covered in the article on HPV types and cancer risk.

Is a Bad Pap Cancer? No

This is the main question and the main reassurance: an abnormality on cytology in the vast majority of cases does NOT mean cancer. ASC-US and LSIL often reflect temporary HPV-related changes the body clears on its own. Even HSIL is precancer, not cancer, and it is well controlled with timely follow-up. There is no need to panic over one report.

Colposcopy and Follow-up After an Abnormality

What happens with a "bad" result: the doctor chooses management by protocol. For mild changes a repeat later or an HPV test is more often ordered; for significant ones — a colposcopy (examining the cervix under magnification) and, if needed, a biopsy. This is not surgery or a verdict but a clarification. Cytology is not confused with a flora smear or PCR for infections.

What to Do with a Cytology Result

Do not diagnose yourself from an abbreviation on the report. Regular cytology is precisely what allows catching changes early; an abnormality means "clarify", not "everything is bad". Testing for infections is a separate topic — for example an STI panel. If the report is confusing, you can upload it for decoding — the service explains the values in plain language.

This article is for informational purposes only and does not replace a doctor's consultation. A cytology result is interpreted by a gynecologist, and with abnormalities a specialist decides on management.

Frequently asked questions

  • Cytology (the Pap test) is a screen for precancerous changes of cervical cells, not a cancer test. It looks for early changes long before symptoms, so they can be controlled in time. The result is reported by the Bethesda system, and a gynecologist assesses the outcome.

  • These are Bethesda categories: NILM — normal; ASC-US — atypical cells of undetermined significance; LSIL — low-grade changes (often HPV-related and self-resolving); HSIL — high-grade changes needing attention. It is a gradation of risk, not a diagnosis of cancer.

  • No. An abnormality on cytology in the vast majority of cases does not mean cancer. ASC-US and LSIL often reflect temporary HPV-related changes that clear on their own. Even HSIL is precancer, not cancer, and is well controlled with follow-up. A doctor assesses the outcome.

  • Most cervical changes are linked to the human papillomavirus, so cytology is often supplemented with a high-risk HPV test. Such co-testing gauges risk more accurately. More on dangerous types is in the article on HPV types and cancer risk.

  • Do not panic: the doctor chooses management by protocol. For mild changes a repeat or HPV test is more often ordered; for significant ones — colposcopy and, if needed, a biopsy. This is a clarifying work-up, not a verdict. A diagnosis is not made from one report.

  • Cytology assesses cervical cell changes for cancer risk, while a flora smear looks at leukocytes and microflora under a microscope. These are different examinations with different goals, and one does not replace the other. Infections are checked with separate tests.

For informational purposes only

This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Please consult a healthcare professional for medical guidance.

Decode your tests with AIUpload a photo or PDF — get a clear explanation of every value in minutes. Start decoding
Still have questions about your health?Ask the AI assistant in plain words — about symptoms, how you feel, sleep, or what a value means. No files needed, first question free. Ask AI about health